NOWDiagnostics Inc. Announces Additions to Leadership Team

Three dynamic individuals joining the NOWDx team

Oct 26, 2015, 13:07 ET from NOWDiagnostics Inc.

SPRINGDALE, Ark., Oct. 26, 2015 /PRNewswire/ -- NOWDiagnostics Inc., based in Springdale, Ark., announced today the addition of three new members to its leadership team: Ann G. Bordelon as Chief Financial Officer/Chief Administrative Officer, Jeff Ellis as the Director of Sales and Marketing and Adam Glasier as Director of Finance.

NOWDiagnostics manufactures and sells a line of unique rapid tests that allow health care providers to conduct simple-to-use, highly accurate tests for a variety of ailments and diseases. Currently, the company manufactures the ADEXUSDx™ hCG test for distribution in the United States and five additional tests in Europe. Unlike others, NOWDiagnostics' tests allow for a one-step process that provides results in 5 to 15 minutes using only a single drop of whole or capillary blood with no laboratory needed. The small drop of blood is obtained from a finger stick. Furthermore, the tests are reviewed by the Federal Drug Administration (FDA) and have proven sensitivity, specificity, accuracy and precision comparable to conventional diagnostic laboratory tests.

All three individuals joining the NOWDiagnostics team bring a deep bench of experience in their respective fields, said NOWDx Chief Executive Officer Kevin Clark.

"With our rapid growth and new product offerings coming to the market, we were ready to expand our leadership team to help us continue our path to changing the diagnostic industry," Clark said. "Ann, Jeff and Adam all bring a wealth of knowledge and skills that will ensure we grow efficiently and effectively, continuing to serve physicians and hospitals with the latest technology in diagnostic testing."

Before joining NOWDx, Ann Bordelon spent nearly 13 years with Walmart. During her time she served as Chief Financial Officer for Walmart's Sam's Club division and CFO of the Asia region. She also served as Global Chief Audit Executive. Prior to joining Wal-Mart, Bordelon worked for Ernst & Young's Assurance and Advisory Services Business where she served two Fortune 100 clients and other clients in the retail and consumer products industry. She also previously worked for Tyson Foods in a variety of finance and accounting positions. 

Jeff Ellis has spent his entire career in sales and sales management. Ellis spent the last 10 years at one of the world's leaders in rapid diagnostic testing – Alere North America. Ellis served as Vice President of Sales for Alere's Hospital Division, Vice President of Marketing for the Alere Cardiac Division and then transitioned to running the U.S. Sales Division for one of Alere's partners, Chembio Diagnostics.

Adam Glasier worked previously at Walmart in the finance and strategy group of the U.S. business division where he was responsible for analysis and execution of strategic initiatives and financial planning. Prior to Walmart, Glasier spent two years in Boston obtaining his master's in business administration from Harvard Business School. During his time in Boston, he worked for two startup companies, where he advised on strategy, financial operations and equity fundraising. Before business school, Glasier spent two years working in investment banking at Stephens Inc. in Little Rock, Ark. At Stephens, he worked on both buy-side and sell-side transactions as well as equity capital raises.

NOWDiagnostics Inc., based in Springdale, Ark., is a leader in innovative diagnostics testing. Its ADEXUSDx™ product line features a lab at your fingertip, using only a single drop of blood to test for a variety of common conditions, illnesses and diseases with results in a matter of minutes. By eliminating the need to send tests to off-site laboratories, NOWDiagnostics has the potential to decrease by days the waiting period to determine test results. The company is currently offering an hCG (pregnancy) test in the United States and Europe, and two cardiac (heart attack) tests and three toxicology tests in Europe. Additional tests are in the development pipeline, including sexually transmitted diseases, more cardiac (heart attack), food intolerances, common infectious diseases and a variety of screening tests. NOWDiagnostics is funded by Bentonville, Ark.-based NewRoad Ventures, a company investing in emerging companies in a variety of growing industries, including retail, consumer packaged goods, health and wellness, data, e-commerce, environmental water quality and logistics. For more information about NOWDiagnostics, visit

Kila Owens
Ghidotti Communications
501.260.7996, ext. 704


SOURCE NOWDiagnostics Inc.